Regional Validation and Recalibration of Clinical Predictive Models for Patients With Acute Heart Failure

Benjamin S Wessler1,2, Robin Ruthazer2, James E Udelson3

  • 1Tufts Cardiovascular Center, Tufts Medical Center, Boston, MA bwessler@tuftsmedicalcenter.org.

Insights

Clinical predictive models (CPMs) for acute heart failure show decreased accuracy across different regions. Region-specific recalibration is essential to improve the reliability of these vital decision-making tools.

Area of Science:

  • Cardiology
  • Health Informatics
  • Clinical Epidemiology

Background:

  • Clinical practice guidelines advocate for validated clinical predictive models (CPMs) in heart failure management.
  • The generalizability of existing heart failure CPMs across diverse populations remains largely unexamined.

Purpose of the Study:

  • To assess the performance and generalizability of North American-derived acute heart failure CPMs in international cohorts.
  • To evaluate the impact of different recalibration strategies on CPM performance across global regions.

Main Methods:

  • Independent external validation of three CPMs predicting in-hospital, 60-day, and 1-year mortality in an international acute heart failure trial (N=4133).
  • Assessment of CPM discrimination (Area Under the Receiver Operating Curve) and calibration across distinct world regions.
  • Comparison of global versus region-specific recalibration techniques.

Main Results:

  • CPM discrimination significantly decreased in all international validation cohorts, with a median reduction in AUC of -0.09.
  • Regional calibration exhibited high variability, ranging from <1% to >50% in performance metrics.
  • Global recalibration failed to adequately improve calibration, whereas region-specific recalibration substantially enhanced CPM performance.

Conclusions:

  • The predictive accuracy and calibration of acute heart failure CPMs differ significantly across global regions.
  • Region-specific recalibration methods are crucial for optimizing the clinical utility and reliability of CPMs in diverse international settings.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
446
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
658
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
309
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
377
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.2K